Taffic Tablets – Uses, Dosage, Composition, Side Effects |Taffic tablet, bictegravir, emtricitabine,

Taffic Tablet is a fixed-dose combination medicine used in the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection. It contains three antiretroviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. Together, these medicines work by blocking different stages of the HIV life cycle, helping to reduce the amount of virus in the blood (viral load) and improve immune function.

Bictegravir is an integrase strand transfer inhibitor that prevents HIV from integrating its genetic material into human DNA. Emtricitabine and tenofovir alafenamide are nucleoside and nucleotide reverse transcriptase inhibitors, which stop the virus from making copies of itself. By combining these three drugs in one tablet, Taffic offers effective viral suppression with a simplified once-daily regimen.

Taffic is prescribed as part of long-term HIV management and is not a cure for HIV or AIDS. However, consistent use as directed by a healthcare professional can help people with HIV live longer, healthier lives and reduce the risk of HIV transmission. It is commonly used in modern HIV treatment due to its strong efficacy and generally favorable tolerability profile.

HIV treatment with combination therapy like Taffic plays a crucial role in controlling symptoms of HIV and AIDS, preventing disease progression, and supporting global HIV prevention and awareness efforts, including initiatives highlighted on World AIDS Day.